Minister Health Dr. Azra highlighted the progress made during recent campaigns, including the fractional Inactivated Polio Vaccine (f-IPV) campaign in August and the Sub-National Immunization Days ...

As we honor two incredible milestones toward reaching a polio-free world this year, we must note that neither would have been possible without vaccines. Thanks to their safety and efficacy, the World ...

The Cen­ter for Bio­med­ical Ad­vanced Re­search and De­vel­op­ment Au­thor­i­ty (BAR­DA) is giv­ing $72 mil­lion to three drug­mak­ers to help for­ti­fy the US sup­ply of bird … ...

GSK Plc, Sanofi, and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human ...

(Reuters) -GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a health official said on Friday during a press briefing.

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

The U.S. has reportedly awarded $72M to GSK (NYSE:GSK), Sanofi (NASDAQ:SNY), and CSL (OTCQX:CSLLY) to expand the production of bird flu vaccines amid an ongoing outbreak among poultry and ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

(Bloomberg) -- GSK Plc, Sanofi and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to ...

The funds will allow for pharmaceutical companies CSL Seqirus, Sanofi, and GSK to "fill and finish"-- a process to fill vaccines from bulk storage into ready-to-use vials or pre-filled syringes.